SkinVive and Skin Boosters

Clinician showing a cheek-area diagram to a woman on a tablet

What an approval does not settle

This hub stays cautious about what an approval means for your own skin and keeps sending you back to a trained professional. Dermatology Times reports that SkinVive was approved for use in all Fitzpatrick skin types, I through VI.

For the approval itself, read AbbVie's announcement, SKINVIVE by JUVEDERM receives U.S. FDA approval, and Dermatology Times' report, FDA approves Skinvive by Juvederm for improving skin smoothness. Glam's take, Skinvive: the new injectable that doubles as skincare, adds a lighter read, so weigh it against the other two.

The product and its labels

The lowest-risk questions come first. They separate the product from the labels people attach to it.

Promises to test before you pay

Read these before you spend money. They test the promises a booster makes.

Age, skin type, training and side effects

These carry the most risk because they depend on your skin and your history, and an article cannot check either.

Settle the injector before the appointment

No answer on this hub replaces an exam. Settle who injects it, and whether you are a fit, before the appointment and not after.

Every question in this chapter